MFG
TEVA icon

Magnus Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Magnus Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Sell
38,034
-50
-0.1% -$1.67K 0.09% 139
2026
Q1 		$1.15M Buy
38,084
+210
+0.6% +$6.76K 0.09% 139
2025
Q4 		$1.18M Buy
37,874
+8,235
+28% +$203K 0.09% 151
2025
Q3 		$599K Buy
+29,639
New +$521K 0.05% 228

Other funds holding TEVA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Magnus Financial Group's TEVA Position: Q2 2026 in Review

Magnus Financial Group reduced its Teva Pharmaceuticals (TEVA) stake by 0.13% in Q2 2026, selling an estimated $1.67K and leaving 38,034 shares worth $1.29M. The position accounts for 0.09% of the portfolio, ranked #139.

Magnus Financial Group first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. 136 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Magnus Financial Group held 38,034 shares of Teva Pharmaceuticals worth $1.29M as of Q2 2026.
  • Magnus Financial Group sold 50 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.67K.
  • Teva Pharmaceuticals made up 0.09% of Magnus Financial Group's portfolio in Q2 2026, its #139 holding.
  • Magnus Financial Group first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 136 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.